Related references
Note: Only part of the references are listed.The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD
S. Ben-Horin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Humanized mice for immune system investigation: progress, promise and challenges
Leonard D. Shultz et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Immunogenicity of Therapeutic Proteins: The Use of Animal Models
Vera Brinks et al.
PHARMACEUTICAL RESEARCH (2011)
Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice
Miranda M. C. van Beers et al.
PHARMACEUTICAL RESEARCH (2011)
Can we prevent immunogenicity of human protein drugs?
D. W. Scott et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study
G. M. Bartelds et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Prediction of Immunogenicity of Therapeutic Proteins Validity of Computational Tools
Christine J. Bryson et al.
BIODRUGS (2010)
Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics
Danika Wullner et al.
CLINICAL IMMUNOLOGY (2010)
Immunological substance testing on human lymphatic micro-organoids in vitro
Christoph Giese et al.
JOURNAL OF BIOTECHNOLOGY (2010)
Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta
Miranda M. C. van Beers et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2010)
Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule
Varsha V. Kapoerchan et al.
MOLECULAR IMMUNOLOGY (2010)
Have we overestimated the benefit of human(ized) antibodies?
Daniel R. Getts et al.
MABS (2010)
Immunological mechanism underlying the immune response to recombinant human protein therapeutics
Melody Sauerborn et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Therapeutic antibodies for autoimmunity and inflammation
Andrew C. Chan et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation
M. K. de Vries et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The analysis of the functions of human B and T cells in humanized NOD/shi-scid/γcnull (NOG) mice (hu-HSC NOG mice)
Yohei Watanabe et al.
INTERNATIONAL IMMUNOLOGY (2009)
Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A
S. Madoiwa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates
Anne S. De Groot et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Epoetin-associated pure red cell aplasia: past, present, and future considerations
June M. McKoy et al.
TRANSFUSION (2008)
New Approaches to Prediction of Immune Responses to Therapeutic Proteins during Preclinical Development
Laura C. A. Perry et al.
DRUGS IN R&D (2008)
Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools
Jason A. Greenbaum et al.
JOURNAL OF MOLECULAR RECOGNITION (2007)
Immunogenicity screening in protein drug development
Ivo Van Walle et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Identification of novel consensus CD4 T-cell epitopes from clade B HIV-1 whole genome that are frequently recognized by HIV-1 infected patients
Simone G. Fonseca et al.
AIDS (2006)
SVMHC:: a server for prediction of MHC-binding peptides
Pierre Donnes et al.
NUCLEIC ACIDS RESEARCH (2006)
Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation
S Hermeling et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Benchmarking B cell epitope prediction: Underperformance of existing methods
MJ Blythe et al.
PROTEIN SCIENCE (2005)
Immunologic mechanisms of EPO-associated pure red cell aplasia
H Schellekens
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2005)
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
F Ishikawa et al.
BLOOD (2005)
Factors influencing the immunogenicity of therapeutic proteins
H Schellekens
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Identification and removal of a promiscuous CD4+T cell epitope from the C1 domain of factor VIII
TD Jones et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Anchor profiles of HLA-specific peptides: Analysis by a novel affinity scoring method and experimental validation
J Desmet et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Development of a human adaptive immune system in cord blood cell-transplanted mice
E Traggiai et al.
SCIENCE (2004)
Mapping of the immunodominant T cell epitopes of the protein topoisomerase
S Veeraraghavan et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE
HJ Bian et al.
METHODS (2004)
T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects
GL Hu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A
S Madoiwa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
T-cell epitope mapping using the ELISPOT approach
DD Anthony et al.
METHODS (2003)
HLA-DQ determines the response to exogenous wheat proteins: A model of gluten sensitivity in transgenic knockout mice
KE Black et al.
JOURNAL OF IMMUNOLOGY (2002)
The ELISPOT assay: An easily transferable method for measuring cellular responses and identifying T cell epitopes
T Mashishi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2002)